Contact Copyright Policy
deitusfrukes
Knowledge platform for experts about celiac disease and glutensensitivity
Dr. Schär Institute
About us
Service
Company
Links
Sitemap
Contact
Copyright Policy
Privacy
Advisory board
Celiac Disease
Gluten Sensitivity
Clinical Areas
Celiac disease
Glutensensitivity
HCP Journal
Editions 2013
Editions 2012
Editions 2011
Editions 2010
Editions 2009
News
Archive
Newsletter
Events
  • Archive
  • Newsletter

Prevalence of celiac disease sharply increases

Annals of Medicine, 2010; 00: 1–9

ABSTRACT: Natural history of celiac disease autoimmunity in a USA cohort followed since 1974
CARLO CATASSI 1,2 , DEBBY KRYSZAK 1 , BUSHRA BHATTI 1 , CRAIG STURGEON 1 , KATHY HELZLSOUER 3 , SANDRA L. CLIPP 3 , DANIEL GELFOND 4 , ELAINE PUPPA 1 , ANTHONY SFERRUZZA 5 & ALESSIO FASANO 1
Annals of Medicine, 2010; 00: 1–9

1 Center for Celiac Research and Mucosal Biology Research Center, University of Maryland School of Medicine, Baltimore, MD, USA, 2 Department of Pediatrics, Universit à Politecnica delle Marche, Ancona, Italy, 3 Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA, 4 The Women & Children ’ s Hospital of Buffalo, Buffalo, NY, USA, and 5 Quest Diagnostics Incorporated, San Juan Capistrano, CA, USA

Abstract Background. The natural history and the possible changes of celiac disease (CD) prevalence over time are still unclear. Objectives. 1) To establish whether loss of tolerance to gluten may occur at any age; 2) to investigate possible changes of CD prevalence over time; and 3) to investigate CD-related co-morbidities.

Methods. We analyzed 3,511 subjects with matched samples from 1974 (CLUE I) and 1989 (CLUE II). To avoid a selection bias regarding survival, we also screened 840 CLUE I participants who deceased after the 1974 survey. Outcome measure. CD autoimmunity (positivity to auto-antibodies) over time.

Results. CD autoimmunity was detected in seven subjects in 1974 (prevalence 1:501) and in an additional nine subjects in 1989 (prevalence 1:219). Two cases of CD autoimmunity were found among the 840 subjects deceased after CLUE I. Compared to controls, untreated CD subjects showed increased incidence of osteoporosis and associated autoimmune disorders, but they did not reach statistical signifi cance.

Conclusions. During a 15-year period CD prevalence increased 2-fold in the CLUE cohort and 5-fold overall in the US since 1974. The CLUE study demonstrated that this increase was due to an increasing number of subjects that lost the immunological tolerance to gluten in their adulthood.

Dr. Schär

Dr. Schär
Dr. Schär AG / SPA
Find out more
Our brandsSchär

Dr. Schär Institute News

Dr. Schär Institute News
Register here, free of charge, for the Newsletter and "Dr. Schär Institute Forum".
Find out more

SHARE

FacebookTwitterLinkedInFavoritesFlickrTell a friend
Sitemap | Copyright Policy | Privacy
Dr. Schär AG / SPA, Winkelau 9, 39014 Burgstall (BZ) Italy.
Mwst Nr. IT00605750215, CCIAA BZ 88727, Cap. Soc. 1.100.000 Euro | professional@schaer.com

Next event

Digestive Disease Week
Location: Orlando, FL
Date: May 18 -21-2013
Find out more

Forgotten password?

Sign in

Register here for free